About me
Dr. Bassam Damaj is a biotech entrepreneur and pharmaceutical innovator with over 25 years of experience building science-based ventures.
He has founded 7 companies, led 3 IPOs, and raised over $500M across the U.S., EU, and MENA.
As CEO of Veos Pharmaceuticals, he leads the development of ThymoTropin™, the first natural and clinically validated myostatin regulator, designed to combat sarcopenia by preserving muscle growth, strength, and endurance in aging populations.
His expertise spans biotechnology, functional ingredients, clinical development, and global strategic partnerships — with a focus on healthy aging and longevity.
Skills
- iotech innovation and venture development
- Cleantech product scaling and deployment
- Circular economy and sustainability strategy
- IP creation, patent filing, and licensing deals
- Regulatory strategy for GRAS and EFSA markets
- Fundraising and global strategic partnerships
- Product commercialization and go-to-market
- R&D leadership in natural health solutions
- Multinational health and climate project design
- Functional Ingredient Innovation
- Biotech R&D Strategy
- Myostatin Pathway Science
- Aging, Sarcopenia, and Mobility Health
- GMP Ingredient Supply Chain
- Healthspan & Longevity Product Development
Interests
- Nature-based emission reduction platforms
- Horizon Europe collaboration opportunities
- Heavy metal removal from wastewater systems
- Methane and H₂S reduction in agri systems
- EU Green Deal-aligned innovation projects
- Bio-based alternatives to synthetic inputs
- Environmental biotech and global scale-up
- Healthy Aging & Preventive Health
- Clinical Innovation in Muscle Preservation
- Ingredient Integration into Local Brands
- Regulatory Support & FFC Enablement
- Cross-border Licensing and Co-development
- Evidence-Based Nutrition & Bioactives
- artnering with JCROs, CDMOs & D2C Platforms
- Collaborating with Pharma & Supplement Leaders
Additional questions
Areas od activity
Pharmaceutical industry Health innovation